PAVmed Inc. PAVM
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 50.00% | -57.69% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 50.00% | -57.69% | |||
| Cost of Revenue | 25.77% | 14.12% | |||
| Gross Profit | -18.67% | -127.27% | |||
| SG&A Expenses | -25.96% | 32.98% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -12.44% | 17.53% | |||
| Operating Income | 12.61% | -18.11% | |||
| Income Before Tax | -520.11% | 61.41% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -520.11% | 61.41% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 20.92% | -32.80% | |||
| Net Income | -8,873.33% | 95.25% | |||
| EBIT | 12.61% | -18.11% | |||
| EBITDA | 12.63% | -18.13% | |||
| EPS Basic | 80.23% | -1,074.77% | |||
| Normalized Basic EPS | 68.58% | -1,138.14% | |||
| EPS Diluted | 80.23% | -8.68% | |||
| Normalized Diluted EPS | 68.58% | -1,138.14% | |||
| Average Basic Shares Outstanding | 296.60% | 76.59% | |||
| Average Diluted Shares Outstanding | 296.60% | 76.59% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||